You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Taxane Refractory

Showing 1 - 25 of 9,237
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer Trial in Winston-Salem (Omeprazole 80 mg twice daily)

Recruiting
  • Prostate Cancer
  • +2 more
  • Omeprazole 80 mg twice daily
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Metastatic Triple Negative Breast Cancer Trial in Houston (L-NMMA, Docetaxel, Amlodipine)

Completed
  • Metastatic Triple Negative Breast Cancer
  • Houston, Texas
    Houston Methodist Hospital
Oct 12, 2021

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Carcinoma
  • +3 more
  • Palo Alto, California
  • +9 more
May 12, 2022

Ovarian Cancer Trial in Wuhan (KM1, Chemotherapy)

Not yet recruiting
  • Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Jan 5, 2023

HER2-positive Breast Cancer, Brain Metastases Trial in Beijing, Guangzhou, Hangzhou (Trastuzumab, Taxanes, Pertuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Brain Metastases
  • Beijing, Beijing, China
  • +2 more
May 28, 2021

Triple-negative Breast Cancer Trial in Milano (Fasting-mimicking diet, Metformin, Preoperative chemo)

Active, not recruiting
  • Triple-negative Breast Cancer
  • Fasting-mimicking diet
  • +2 more
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 17, 2023

Castration Resistant Prostate Cancer Trial in Fountain Valley (NRX 194204)

Completed
Has Results
  • Castration Resistant Prostate Cancer
  • NRX 194204
  • Fountain Valley, California
    Lalita Pandit, MD
Apr 23, 2021

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Malignant Ovarian Epithelial Tumor
  • +9 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 10, 2022

Cancer Trial in United States (Gemcitabine, Nab-paclitaxel)

Recruiting
  • Cancer
  • Aurora, Colorado
  • +3 more
Oct 28, 2021

Urothelial Carcinoma of the Urinary Bladder Trial in New York (Cabazitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma of the Urinary Bladder
  • New York, New York
    Columbia University Medical Center- HIP
Feb 3, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Enzalutamide 40mg
  • +4 more
  • Bellinzona, Switzerland
  • +1 more
Nov 6, 2023

Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Taxane and Carboplatin
  • +2 more
  • (no location specified)
Apr 25, 2023

CIPN - Chemo-Induced Peripheral Neuropathy, Breast Cancer Trial in Copenhagen (Elasto-Gel™ mitts for hands: TM7008, and slippers

Recruiting
  • CIPN - Chemotherapy-Induced Peripheral Neuropathy
  • Breast Cancer
  • Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA
  • Copenhagen, Denmark
    Maria E Lendorf
Jun 23, 2023

Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)

Not yet recruiting
  • Vitamin D Deficiency
  • Peripheral Neuropathy
  • Vitamin D
  • (no location specified)
May 2, 2023

Gastro-Oesophageal Cancer Trial in Worldwide (Regorafenib, Nivolumab, Docetaxel)

Recruiting
  • Gastro-Oesophageal Cancer
  • Scottsdale, Arizona
  • +74 more
Jan 11, 2022

Breast Tumors, Breast Diseases, Metastases, Tumor Trial (BNP7787, Placebo)

Completed
  • Breast Neoplasms
  • +2 more
  • (no location specified)
Jul 11, 2022

Breast Carcinoma Trial in Jacksonville (Medical Device Usage and Evaluation, Questionnaire Administration)

Active, not recruiting
  • Breast Carcinoma
  • Medical Device Usage and Evaluation
  • Questionnaire Administration
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 12, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)

Recruiting
  • Triple Negative Breast Cancer
  • Amadora, Lisboa, Portugal
  • +16 more
Jun 10, 2022

Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)

Completed
Has Results
  • Breast Neoplasms
  • Breast Cancer
  • Houston, Texas
  • +2 more
Jan 19, 2023